A later study by Yoo et al. described the mutational landscape in follicular thyroid adenomas (FTA) and follicular carcinoma (FTC), with reference to PTC, including the previously described BRAF-like and RAS-like lesions along with a Non-Braf/Non-Ras (NBNR) group of follicular-derived tumors that behaved in an intermediate fashion. Here, BRAF is linked to thyroid cancer, nonmedullary, 2.